|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes and obesity, pharmaceutical preparation... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for weight... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight... |
|
|
P/S
|
Custom manufacturing of medical products. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes. |
|
|
P/S
|
Pharmaceutical preparations for weight reduction and long-term weight loss maintenance. |
|
|
Invention
|
Syringe device with a dose limiting mechanism and an additional safety mechanism.
A syringe devi... |
|
|
Invention
|
Compositions of glp-1 peptides and preparation thereof.
The invention relates to pharmaceutical ... |
|
|
P/S
|
Custom manufacturing of chemicals, biochemical, and pharmaceuticals. |
|
|
P/S
|
Recorded computer software for predicting medical treatment effects.. Promotion via a website, of... |
|
|
Invention
|
Pharmaceutical formulations.
Disclosed herein are an aqueous pharmaceutical formulation comprisi... |
|
|
Invention
|
Semaglutide for use in medicine.
The present invention is directed to use of the GLP-1 receptor ... |
|
|
P/S
|
Electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medica... |
|
|
P/S
|
Downloadable software in the nature of mobile applications for the treatment of medical condition... |
|
2024
|
Invention
|
Glucose-sensitive albumin-binding derivatives.
This invention relates to glucose-sensitive album... |
|
|
Invention
|
Stable liquid formulations. The application relates to the development of an improved antibody fo... |
|
|
Invention
|
Glp-1 receptor agonists in dementia.
The present invention relates to improved medical therapies... |
|
|
Invention
|
Tri-agonists of the glp-1, gip, and amylin receptors. The present invention relates to a GLP-1-/G... |
|
|
Invention
|
Injection device with machine-readable coding. The present invention provides an injection device... |
|
|
Invention
|
Drug delivery device with drive spring. A drug delivery device comprising a housing in which a sp... |
|
|
Invention
|
Drug delivery device with safety release member. A drug delivery device comprising a needle unit ... |
|
|
Invention
|
Adaptive cartridge holder for drug delivery device. A cartridge holder adapted to receive a cylin... |
|
|
Invention
|
Fixed dose drug delivery device with rotational controller. A drug delivery device comprising a s... |
|
|
Invention
|
Shielded needle unit with lock indicator. A needle unit adapted to be mounted on a drug delivery ... |
|
|
Invention
|
Method and arrangement for non-destructive cci testing. The present invention provides a method o... |
|
|
Invention
|
Methods for preventing unwanted cells arising during differentiation of human pluripotent stem ce... |
|
|
Invention
|
Enrichment of nkx6.1 and c-peptide co-expressing cells derived in vitro from stem cells.
The pre... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes;
pharmaceutical preparations for weigh... |
|
|
Invention
|
An injection device with support ribs for supporting a glass cartridge. The invention relates to ... |
|
|
Invention
|
Site directed mutagenesis of trem-1 antibodies for decreasing viscosity.
Antibodies that are cap... |
|
|
Invention
|
Anti il-6 domain antibodies.
The present invention relates to compounds (e.g. ISVDs, polypeptide... |
|
|
Invention
|
Anti il-6 domain antibodies. The present invention relates to compounds (e.g. ISVDs, polypeptides... |
|
|
Invention
|
Sortilin-1 binders, constructs and uses thereof. A polypeptide comprising a binder, the binder ha... |
|
|
Invention
|
Insulin containing pharmaceutical compositions.
The present invention is in the field of pharmac... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease,... |
|
|
Invention
|
Semaglutide in medical therapy. The present invention relates to semaglutide for use in weight ma... |
|
|
Invention
|
Stable semaglutide compositions and uses thereof.
The present invention relates to pharmaceutica... |
|
|
Invention
|
Highly potent isvd compounds capable of substituting for fviii(a).
The present invention provide... |
|
|
Invention
|
Systems and methods for providing titration dose guidance. A method for providing a titration ins... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
neurodegenerative disorders and diseases. |
|
|
Invention
|
Procoagulant antibodies.
The present invention relates to improved procoagulant antibodies inclu... |
|
|
Invention
|
Fusion compounds and uses thereof.
The invention relates to fusion proteins comprising a GLP-1 p... |
|
|
Invention
|
Pharmaceutical compositions of insulin derivatives. The present invention relates to a compositio... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
cardiovascular diseases, chronic kidney disease... |
|
|
Invention
|
Enhancing neuronal differentiation of neural progenitor cells. The present invention relates to a... |
|
|
Invention
|
Semaglutide in medical therapy. The present invention is directed to use of the GLP-1 receptor ag... |
|
|
Invention
|
Pharmaceutical formulations of an amylin receptor agonist and a glp-1 receptor agonist comprising... |
|
|
Invention
|
Shielded needle unit with actuatable release feature. A drug delivery assembly comprising a drug ... |
|
|
Invention
|
Shielded needle unit with rotating needle. A drug delivery assembly comprising a drug-filled cart... |
|
|
Invention
|
Shielded needle unit with actuatable mounting feature. A drug delivery assembly comprising a drug... |
|
|
Invention
|
Shielded needle unit with actuatable container coupling. A needle assembly comprising a needle un... |
|
|
Invention
|
Drug delivery assembly with double-dose prevention. A drug delivery assembly comprises a drug del... |
|
|
Invention
|
Shielded needle unit with axial mounting feature. A drug delivery assembly comprising a drug deli... |
|
|
Invention
|
Rnai oligonucleotide conjugates.
Lipid-conjugated oligonucleotide are provided herein that inhib... |
|
|
Invention
|
Compositions and methods for inhibiting ketohexokinase (khk).
Oligonucleotides are provided here... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of liver
diseases. |
|
|
Invention
|
Ingestible device with detachment of tissue penetrating member.
An ingestible device (200), comp... |
|
2023
|
Invention
|
Dose logging assembly with rotational transmission feature.
Add-on device comprising a housing, ... |
|
|
Invention
|
Crystalline forms of n-{[(s)-{[3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1h-pyrazol-1-yl][4-(triflu... |
|
|
Invention
|
Pyrazolopyrimidines, compositions comprising them and uses thereof.
The present document relates... |
|
|
Invention
|
Systems and methods for personalized insulin titration.
A computing system for providing a titra... |
|
2022
|
Invention
|
Tetrahydropyridazines, compositions comprising them and uses thereof.
The present document relat... |
|
|
Invention
|
Photochemical approach to c-terminal a-amidation.
The present invention relates to a photochemic... |
|
|
Invention
|
Method for providing a cell population enriched in neurons and precursors thereof.
The present i... |
|
|
Invention
|
Injection device |
